Clinical Trial Update: Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) [Phase 1]

View source ↗

Summary

Phase 1 persistency study of aP/Tdap booster vaccines in adults completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• aP/Tdap booster vaccine (diphtheria and tetanus toxoids and acellular pertussis vaccine)

Snippet

Sponsor: Novartis | Conditions: Pertussis | Phase 1 | Status: COMPLETED | Results posted: 2016-02-12